Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Am J Public Health ; 114(4): 407-414, 2024 04.
Artigo em Inglês | MEDLINE | ID: mdl-38478867

RESUMO

Objectives. To produce a database of private insurance hearing aid mandates in the United States and quantify the share of privately insured individuals covered by a mandate. Methods. We used health-related policy surveillance methods to create a database of private insurance hearing aid mandates through January 2023. We coded salient features of mandates and combined policy data with American Community Survey and Medicare Expenditure Panel Survey-Insurance Component data to estimate the share of privately insured US residents covered by a mandate from 2008 to 2022. Results. A total of 26 states and 1 territory had private insurance hearing aid mandates. We found variability for mandate exceptions, maximum age eligibility, allowable frequency of benefit use, and coverage amounts. Between 2008 and 2022 the proportion of privately insured youths (aged ≤ 18 years) living where there was a private insurance hearing aid mandate increased from 3.4% to 18.7% and the proportion of privately insured adults (19-64 years) increased from 0.3% to 4.6%. Conclusions. Hearing aid mandates cover a small share of US residents. Mandate exceptions in several states limit coverage, particularly for adults. Public Health Implications. A federal mandate would improve hearing aid access. States can also improve access by adopting exception-free mandates with limited utilization management and no age restrictions. (Am J Public Health. 2024;114(4):407-414. https://doi.org/10.2105/AJPH.2023.307551).


Assuntos
Auxiliares de Audição , Cobertura do Seguro , Adulto , Adolescente , Humanos , Estados Unidos , Idoso , Epidemiologia Legal , Medicare , Política de Saúde , Seguro Saúde
2.
Tob Control ; 2023 Jul 21.
Artigo em Inglês | MEDLINE | ID: mdl-37479474

RESUMO

OBJECTIVE: To use a standardised e-cigarette tax measure to examine the impact of e-cigarette taxes on the price and sales of e-cigarettes and cigarettes in the USA. DESIGN: We used State Line versions of NielsenIQ Retail Scanner data from quarter 4 of 2014 through quarter 4 of 2019 to calculate e-cigarette and cigarette prices and sales in 23 US states. We then estimated how these outcomes are associated with standardised state-level e-cigarette taxes, controlling for state fixed effects, quarter-by-year fixed effects, cigarette taxes, other tobacco control policies and other state-level time-varying characteristics. RESULTS: A real $1 increase in the e-cigarette standardised tax increases the price of 1 mL of e-liquid between $0.43 and $0.59 depending on specification. Controlling for fixed effects and cigarette taxes, a 10% increase in e-cigarette taxes is estimated to reduce e-cigarette sales by 0.5% and increase cigarette sales by 0.1%, though both results are attenuated and statistically insignificant in a model with full controls. CONCLUSIONS: Our study finds that e-cigarette taxes increase e-cigarette retail prices by approximately half of the tax. Further, e-cigarette taxes are associated with reduced sales of e-cigarettes and increased sales of cigarettes in some specifications. Our estimates are sizably lower than from other studies using sales and survey data.

3.
N Engl J Med ; 388(9): 824-832, 2023 Mar 02.
Artigo em Inglês | MEDLINE | ID: mdl-36856618

RESUMO

BACKGROUND: By the end of 2022, nearly 20 million workers in the United States have gained paid-sick-leave coverage from mandates that require employers to provide benefits to qualified workers, including paid time off for the use of preventive services. Although the lack of paid-sick-leave coverage may hinder access to preventive care, current evidence is insufficient to draw meaningful conclusions about its relationship to cancer screening. METHODS: We examined the association between paid-sick-leave mandates and screening for breast and colorectal cancers by comparing changes in 12- and 24-month rates of colorectal-cancer screening and mammography between workers residing in metropolitan statistical areas (MSAs) that have been affected by paid-sick-leave mandates (exposed MSAs) and workers residing in unexposed MSAs. The comparisons were conducted with the use of administrative medical-claims data for approximately 2 million private-sector employees from 2012 through 2019. RESULTS: Paid-sick-leave mandates were present in 61 MSAs in our sample. Screening rates were similar in the exposed and unexposed MSAs before mandate adoption. In the adjusted analysis, cancer-screening rates were higher among workers residing in exposed MSAs than among those in unexposed MSAs by 1.31 percentage points (95% confidence interval [CI], 0.28 to 2.34) for 12-month colorectal cancer screening, 1.56 percentage points (95% CI, 0.33 to 2.79) for 24-month colorectal cancer screening, 1.22 percentage points (95% CI, -0.20 to 2.64) for 12-month mammography, and 2.07 percentage points (95% CI, 0.15 to 3.99) for 24-month mammography. CONCLUSIONS: In a sample of private-sector workers in the United States, cancer-screening rates were higher among those residing in MSAs exposed to paid-sick-leave mandates than among those residing in unexposed MSAs. Our results suggest that a lack of paid-sick-leave coverage presents a barrier to cancer screening. (Funded by the National Cancer Institute.).


Assuntos
Neoplasias da Mama , Neoplasias Colorretais , Detecção Precoce de Câncer , Licença Médica , Humanos , Neoplasias da Mama/diagnóstico , Neoplasias da Mama/economia , Neoplasias Colorretais/diagnóstico , Neoplasias Colorretais/economia , Detecção Precoce de Câncer/economia , Detecção Precoce de Câncer/estatística & dados numéricos , Mamografia/estatística & dados numéricos , Programas Obrigatórios/economia , Programas Obrigatórios/legislação & jurisprudência , Programas Obrigatórios/estatística & dados numéricos , Salários e Benefícios/economia , Salários e Benefícios/legislação & jurisprudência , Salários e Benefícios/estatística & dados numéricos , Licença Médica/economia , Licença Médica/legislação & jurisprudência , Licença Médica/estatística & dados numéricos , Estados Unidos/epidemiologia , População Urbana/estatística & dados numéricos , Acessibilidade aos Serviços de Saúde/economia , Acessibilidade aos Serviços de Saúde/legislação & jurisprudência , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos
4.
Tob Control ; 32(e2): e251-e254, 2023 08.
Artigo em Inglês | MEDLINE | ID: mdl-34911814

RESUMO

INTRODUCTION: E-cigarette taxes have been enacted by 30 states through April 2020. E-cigarette tax schemas vary, in contrast to cigarette taxes in the USA that are levied almost exclusively as excise taxes per pack. Some states use excise taxes on liquid and containers, others ad valorem taxes on wholesale prices and others sales taxes. It is therefore difficult to understand the relative magnitudes of these e-cigarette taxes and the overall e-cigarette tax size relative to the cigarette tax size. OBJECTIVE: To create and publish a database of state and local quarterly e-cigarette taxes from 2010 to 2020, standardised as the rate per millilitre of fluid. METHODS: Using Universal Product Code-level e-cigarette sales from the NielsenIQ Retail Scanner Data along with e-cigarette product characteristics collected from internet searches and visits to e-cigarette retailers, we develop a method to standardise e-cigarette taxes as an equivalent average excise tax rate measured per millilitre of fluid. RESULTS: In 2020, the average American resided in a location with $3.08 in cigarette taxes and $0.34 in e-cigarette taxes (assuming 1 pack=0.7 fluid mL). CONCLUSIONS: The public availability of this state and local standardised e-cigarette tax data will allow tobacco control researchers to study the relationship between e-cigarette taxes and tobacco and related outcomes more effectively.


Assuntos
Sistemas Eletrônicos de Liberação de Nicotina , Indústria do Tabaco , Produtos do Tabaco , Humanos , Estados Unidos , Fumar , Impostos , Comércio
5.
J Interprof Care ; 34(3): 418-421, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31544550

RESUMO

Lesbian, gay, bisexual, transgender, queer, and intersex people have unique health and health care needs that are inadequately met. An eight-hour symposium was developed at the George Washington University (GW) to better prepare health professional students and faculty to care for sexual and gender minority patients. This study compared surveyed learner knowledge, attitudes, and clinical preparedness, as well as perceived value of interprofessional learning, before and after the symposium. Learners at post-test were compared to an interprofessional group who did not attend the symposium. Results indicated statistically significant improvements for confidence in all learning objectives (p < .05) and for two of three factors (knowledge and clinical preparedness) of the Lesbian, Gay, Bisexual, and Transgender Development of Clinical Skills Scale (LGBT-DOCSS). In contrast to the comparison group, symposium participants at posttest rated higher on learning objectives, the attitudes and knowledge LGBT-DOCSS factors, and perceived value of interprofessional learning as measured by four items from the Interprofessional Learning Scale. This innovation is a starting point to address an identified learning gap. Findings support the benefit of greater curricular integration of sexual and gender minority health content through interprofessional learning to ensure preparedness of all practitioners.


Assuntos
Educação Interprofissional , Saúde das Minorias/educação , Minorias Sexuais e de Gênero , Estudantes de Ciências da Saúde , Adulto , Avaliação Educacional , Feminino , Humanos , Masculino
6.
Oncol Nurs Forum ; 46(5): E171-E179, 2019 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-31424457

RESUMO

OBJECTIVES: To evaluate the impact of the Executive Training on Navigation and Survivorship (Executive Training) online training course, designed by the George Washington University Cancer Center, on nurses and other healthcare professionals. SAMPLE & SETTING: A volunteer sample of 499 healthcare professionals, including nurses and patient navigators, were recruited through multiple Internet-based channels. METHODS & VARIABLES: Participants completed questionnaires before and after each module and at the end of the training. Descriptive statistics were calculated, and paired t tests were used to assess pre- and post-test learning confidence gains for each module. Qualitative feedback from participants was also summarized. RESULTS: From pre- to post-test, each group demonstrated statistically significant improvements in confidence (p < 0.05) for all seven training modules. Confidence gains were statistically significant for 19 of 20 learning objectives (p < 0.05). Overall rating scores and qualitative feedback were positive. IMPLICATIONS FOR NURSING: The Executive Training course prepares healthcare professionals from diverse backgrounds to establish navigation and survivorship programs. In addition, the training content addresses gaps in nursing education on planning and budgeting that can improve success.


Assuntos
Sobreviventes de Câncer , Pessoal de Saúde/educação , Educação de Pacientes como Assunto/organização & administração , Navegação de Pacientes/organização & administração , Sobrevivência , Adulto , Orçamentos , Comportamento do Consumidor , Educação a Distância , Educação Continuada em Enfermagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Enfermagem Oncológica/educação , Educação de Pacientes como Assunto/economia , Navegação de Pacientes/economia , Avaliação de Programas e Projetos de Saúde , Adulto Jovem
7.
Health Econ Rev ; 8(1): 12, 2018 Jun 14.
Artigo em Inglês | MEDLINE | ID: mdl-29904805

RESUMO

Patient navigation has expanded as a promising approach to improve cancer care coordination and patient adherence. This paper addresses the need to identify the evidence on the economic impact of patient navigation in colorectal cancer, following the Health Economic Evaluation Publication Guidelines. Articles indexed in Medline, Cochrane, CINAHL, and Web of Science between January 2000 and March 2017 were analyzed. We conducted a systematic review of the literature using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The quality assessment of the included studies was based on the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. Inclusion criteria indicated that the paper's subject had to explicitly address patient navigation in colorectal cancer and the study had to be an economic evaluation. The search yielded 243 papers, 9 of which were finally included within this review. Seven out of the nine studies included met standards for high-quality based on CHEERS criteria. Eight concluded that patient navigation programs were unequivocally cost-effective for the health outcomes of interest. Six studies were cost-effectiveness analyses. All studies computed the direct costs of the program, which were defined a minima as the program costs. Eight of the reviewed studies adopted the healthcare system perspective. Direct medical costs were usually divided into outpatient and inpatient visits, tests, and diagnostics. Effectiveness outcomes were mainly assessed through screening adherence, quality of life and time to diagnostic resolution. Given these outcomes, more economic research is needed for patient navigation during cancer treatment and survivorship as well as for patient navigation for other cancer types so that decision makers better understand costs and benefits for heterogeneous patient navigation programs.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA